The biotechnology group specializes in discovering and developing innovative small molecule drugs for the treatment of diseases with the greatest clinical need, such as cancer, fibrosis, and respiratory disorders. Research projects at various stages of development are mainly based on ideas from research teams and scientists employed by the group, but are also acquired through licensing know-how and intellectual property from academic institutions and other biotech companies. Most projects are carried out in collaboration with leading universities and clinical centers worldwide. The business model involves partnering developed projects with large pharmaceutical and biotechnology companies.
